Systemic Disease Associations with Disorders of Gut–Brain Interaction and Gastrointestinal Transit: A Review

References

• Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. 2017;23(2):151–163. doi:10.5056/jnm16214
   PubMed Web of Science ®Google Scholar
• Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257–1261. doi:10.1053/j.gastro.2016.03.035
   PubMed Web of Science ®Google Scholar
• Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–114.e3. doi:10.1053/j.gastro.2020.04.014
   PubMed Web of Science ®Google Scholar
• Pasricha PJ, Grover M, Yates KP, et al. Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathologic features. Gastroenterology. 2021;160(6):2006–2017. doi:10.1053/j.gastro.2021.01.230
   PubMed Web of Science ®Google Scholar
• Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi:10.1016/j.diabres.2017.03.024
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817. doi:10.1212/WNL.43.4.817
   PubMed Web of Science ®Google Scholar
• Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518–1522. doi:10.2337/dc05-2228
   PubMed Web of Science ®Google Scholar
• Young MJ, Boulton AJM, MacLeod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150–154. doi:10.1007/BF00400697
   PubMed Web of Science ®Google Scholar
• Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go? J Diabetes Investig. 2011;2(1):18–32. doi:10.1111/j.2040-1124.2010.00070.x
   PubMed Web of Science ®Google Scholar
• Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med. 1980;92(2_Part_2):301–303. doi:10.7326/0003-4819-92-2-301
   Web of Science ®Google Scholar
• Grover M, Farrugia G, Lurken MS, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011;140(5):1575–1585. doi:10.1053/j.gastro.2011.01.046
   PubMed Web of Science ®Google Scholar
• Harberson J, Thomas RM, Harbison SP, Parkman HP. Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies. Dig Dis Sci. 2010;55(2):359–370. doi:10.1007/s10620-009-1071-2
   PubMed Web of Science ®Google Scholar
• Faussone-Pellegrini MS, Grover M, Pasricha PJ, et al. Ultrastructural differences between diabetic and idiopathic gastroparesis. J Cell Mol Med. 2012;16(7):1573–1581. doi:10.1111/j.1582-4934.2011.01451.x
   Web of Science ®Google Scholar
• Zandecki M, Vanden Berghe P, Depoortere I, et al. Characterization of myenteric neuropathy in the jejunum of spontaneously diabetic BB‐rats. Neurogastroenterol Motil. 2008;20(7):818–828. doi:10.1111/j.1365-2982.2008.01091.x
   Web of Science ®Google Scholar
• Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15 000 adults. Arch Intern Med. 2001;161(16):1989–1996. doi:10.1001/archinte.161.16.1989
   PubMedGoogle Scholar
• Kofod-Andersen K, Tarnow L. Prevalence of gastroparesis-related symptoms in an unselected cohort of patients with type 1 diabetes. J Diabetes Complications. 2012;26(2):89–93. doi:10.1016/j.jdiacomp.2012.02.009
   Web of Science ®Google Scholar
• Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American neurogastroenterology and motility society and the society of nuclear medicine. J Nucl Med Technol. 2008;36(1):44–54. doi:10.2967/jnmt.107.048116
   PubMedGoogle Scholar
• Maurer AH, Abell T, Bennett P, et al. Appropriate use criteria for gastrointestinal transit scintigraphy. J Nucl Med. 2020;61(3):11N–17N.
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Chedid V, Mandawat A, Erwin PJ, Murad MH. Effects of promotility agents on gastric emptying and symptoms: a systematic review and meta-analysis. Gastroenterology. 2019;156(6):1650–1660. doi:10.1053/j.gastro.2019.01.249
   PubMed Web of Science ®Google Scholar
• Rayner CK, Horowitz M. Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited? J Clin Invest. 2006;116(2):299–302. doi:10.1172/JCI27758
   Web of Science ®Google Scholar
• Lee YY, Erdogan A, Rao SSC. How to assess regional and whole gut transit time with wireless motility capsule. J Neurogastroenterol Motil. 2014;20(2):265–270. doi:10.5056/jnm.2014.20.2.265
   PubMed Web of Science ®Google Scholar
• Lee AA, Rao S, Nguyen LA, et al. Validation of diagnostic and performance characteristics of the wireless motility capsule in patients with suspected gastroparesis. Clin Gastroenterol Hepatol. 2019;17(9):1770–1779.e2. doi:10.1016/j.cgh.2018.11.063
   PubMed Web of Science ®Google Scholar
• Hasler WL, Rao SSC, McCallum RW, et al. Influence of gastric emptying and gut transit testing on clinical management decisions in suspected gastroparesis. Clin Transl Gastroenterol. 2019;10(10):e00084. doi:10.14309/ctg.0000000000000084
   Web of Science ®Google Scholar
• Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology. 1988;94(3):739–744. doi:10.1016/0016-5085(88)90248-x
   PubMed Web of Science ®Google Scholar
• Eliasson B, Björnsson E, Urbanavicius V, et al. Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption. Diabetologia. 1995;38(1):79–85. doi:10.1007/BF02369356
   Web of Science ®Google Scholar
• Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18–37; quiz 38. doi:10.1038/ajg.2012.373
   Web of Science ®Google Scholar
• Thapa B, Ramphul K. Paraneoplastic Syndromes. StatPearls [Internet]; 2020.
   Google Scholar
• Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. In: Mayo Clinic Proceedings. 2010;(85):838–854.
   Google Scholar
• Henry K. Paraneoplastic syndromes: definitions, classification, pathophysiology and principles of treatment. In: Seminars in Diagnostic Pathology. 2019;(36):204–210.
   Google Scholar
• Hirano T, Miyauchi E, Inoue A, et al. Two cases of pseudo-achalasia with lung cancer: case report and short literature review. Respir Investig. 2016;54(6):494–499. doi:10.1016/j.resinv.2016.04.006
   PubMed Web of Science ®Google Scholar
• Malhotra K, Georgiades IB, Davies J. Functional colonic obstruction in an adult as a presenting feature of thymoma. Ann R Coll Surg Engl. 2011;93(6):e61–e63. doi:10.1308/147870811X589588
   Google Scholar
• Liu K, Kwok A. Paraneoplastic syndrome: a rare cause of gastrointestinal dysmotility. Clin Gastroenterol Hepatol. 2015;13(1):A25–A26. doi:10.1016/j.cgh.2014.07.038
   Web of Science ®Google Scholar
• Kiers L, Altermatt HJ, Lennon VA. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma. Mayo Clin Proc. 1991;66(12):1209–1216. doi:10.1016/s0025-6196(12)62471-9
   Web of Science ®Google Scholar
• Lipowska AM, Micic D, Cavallo A, McDonald E. Autoimmune gastrointestinal dysmotility due to small cell lung cancer. BMJ Case Rep. 2017;2017. doi:10.1136/bcr-2017-220890
   Google Scholar
• Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998;50(3):652–657. doi:10.1212/wnl.50.3.652
   PubMed Web of Science ®Google Scholar
• Shafi MA. Gastrointestinal motility issues in cancer patients. Curr Gastroenterol Rep. 2019;21(12):69. doi:10.1007/s11894-019-0738-x
   Google Scholar
• Kashyap P, Farrugia G. Enteric autoantibodies and gut motility disorders. Gastroenterol Clin North Am. 2008;37(2):397–410. doi:10.1016/j.gtc.2008.02.005
   Web of Science ®Google Scholar
• Zerbib F, Bredenoord AJ, Fass R, et al. ESNM/ANMS consensus paper: diagnosis and management of refractory gastro-esophageal reflux disease. Neurogastroenterol Motil. 2020:e14075. doi:10.1111/nmo.14075
   Web of Science ®Google Scholar
• Yadlapati R, Vaezi MF, Vela MF, et al. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. Am J Gastroenterol. 2018;113(7):980–986. doi:10.1038/s41395-018-0045-4
   PubMed Web of Science ®Google Scholar
• Stylopoulos N, Bunker CJ, Rattner DW. Development of achalasia secondary to laparoscopic nissen fundoplication. J Gastrointest Surg. 2002;6(3):368–378. doi:10.1016/S1091-255X(02)00019-7
   Web of Science ®Google Scholar
• Wehrli NE, Levine MS, Rubesin SE, Katzka DA, Laufer I. Secondary achalasia and other esophageal motility disorders after laparoscopic nissen fundoplication for gastroesophageal reflux disease. Am J Roentgenol. 2007;189(6):1464–1468. doi:10.2214/AJR.07.2582
   Web of Science ®Google Scholar
• Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0(©). Neurogastroenterol Motil. 2021;33(1):e14058. doi:10.1111/nmo.14058
   PubMed Web of Science ®Google Scholar
• de Bortoli N, Gyawali PC, Roman S, et al. Hypercontractile esophagus from pathophysiology to management: proceedings of the pisa symposium. Am J Gastroenterol. 2021;116(2):263–273. doi:10.14309/ajg.0000000000001061
   Web of Science ®Google Scholar
• Kahn A, Al-Qaisi MT, Obeid RA, et al. Clinical features and long-term outcomes of lower esophageal sphincter-dependent and lower esophageal sphincter-independent jackhammer esophagus. Neurogastroenterol Motil. 2019;31(2):e13507. doi:10.1111/nmo.13507
   PubMed Web of Science ®Google Scholar
• Yadlapati R, Hungness ES, Pandolfino JE. Complications of antireflux surgery. Am J Gastroenterol. 2018;113(8):1137–1147. doi:10.1038/s41395-018-0115-7
   PubMed Web of Science ®Google Scholar
• Christiansen J, Jensen HE, Ejby-Poulsen P, Bardram L, Henriksen FW. Prospective controlled vagotomy trial for duodenal ulcer: primary results, sequelae, acid secretion, and recurrence rates two to five years after operation. Ann Surg. 1981;193(1):49–55. doi:10.1097/00000658-198101000-00008
   Web of Science ®Google Scholar
• Berkowitz N, Schulman LL, McGregor C, Markowitz D. Gastroparesis after lung transplantation: potential role in postoperative respiratory complications. Chest. 1995;108(6):1602–1607. doi:10.1378/chest.108.6.1602
   Web of Science ®Google Scholar
• Raviv Y, D’Ovidio F, Pierre A, et al. Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes. Clin Transplant. 2012;26(1):133–142. doi:10.1111/j.1399-0012.2011.01434.x
   PubMed Web of Science ®Google Scholar
• Fich A, Neri M, Camilleri M, Kelly KA, Phillips SF. Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J Clin Gastroenterol. 1990;12(5):505–512. doi:10.1097/00004836-199010000-00005
   Web of Science ®Google Scholar
• Lu D, Altieri MS, Yang J, et al. Investigating rates of reoperation or postsurgical gastroparesis following fundoplication or paraesophageal hernia repair in New York State. Surg Endosc. 2019;33(9):2886–2894. doi:10.1007/s00464-018-6588-z
   Web of Science ®Google Scholar
• Akindipe OA, Faul JL, Vierra MA, Triadafilopoulos G, Theodore J. The surgical management of severe gastroparesis in heart/lung transplant recipients. Chest. 2000;117(3):907–910. doi:10.1378/chest.117.3.907
   Web of Science ®Google Scholar
• Ahmad A, Kornrich DB, Krasner H, et al. Prevalence of dumping syndrome after laparoscopic sleeve gastrectomy and comparison with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2019;29(5):1506–1513. doi:10.1007/s11695-018-03699-y
   PubMed Web of Science ®Google Scholar
• Csendes A, Braghetto I. Changes in the anatomy and physiology of the distal esophagus and stomach after sleeve gastrectomy. J Obes Weight Loss Ther. 2016;6(1). doi:10.4172/2165-7904.1000297
   Google Scholar
• Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T. The incidence of parkinson’s disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46(4):292–300. doi:10.1159/000445751
   PubMed Web of Science ®Google Scholar
• Yang W, Hamilton JL, Kopil C, et al. Current and projected future economic burden of parkinson’s disease in the US. NPJ Park Dis. 2020;6(1):1–9.
   Web of Science ®Google Scholar
• Hawkes CH, Del Tredici K, Braak H. Parkinson’s disease: a dual‐hit hypothesis. Neuropathol Appl Neurobiol. 2007;33(6):599–614. doi:10.1111/j.1365-2990.2007.00874.x
   PubMed Web of Science ®Google Scholar
• Cersosimo MG, Raina GB, Pecci C, et al. Gastrointestinal manifestations in parkinson’s disease: prevalence and occurrence before motor symptoms. J Neurol. 2013;260(5):1332–1338. doi:10.1007/s00415-012-6801-2
   PubMed Web of Science ®Google Scholar
• Edwards L, Quigley EM, Hofman R, Pfeiffer RF. Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study. Mov Disord. 1993;8(1):83–86. doi:10.1002/mds.870080115
   Web of Science ®Google Scholar
• Natale G, Kastsiushenka O, Fulceri F, Ruggieri S, Paparelli A, Fornai F. MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut. Brain Res. 2010;1355:195–206. doi:10.1016/j.brainres.2010.07.076
   PubMed Web of Science ®Google Scholar
• Toti L, Travagli RA. Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis. Am J Physiol Gastrointest Liver Physiol. 2014;307(10):G1013–G1023. doi:10.1152/ajpgi.00258.2014
   Web of Science ®Google Scholar
• Zhu HC, Zhao J, Luo CY, Li QQ. Gastrointestinal dysfunction in a parkinson’s disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus. J Mol Neurosci. 2012;47(1):15–25. doi:10.1007/s12031-011-9560-0
   PubMed Web of Science ®Google Scholar
• Colucci M, Cervio M, Faniglione M, et al. Intestinal dysmotility and enteric neurochemical changes in a parkinson’s disease rat model. Auton Neurosci. 2012;169(2):77–86. doi:10.1016/j.autneu.2012.04.005
   Web of Science ®Google Scholar
• Sampson TR, Debelius JW, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of parkinson’s disease. Cell. 2016;167(6):1469–1480.e12. doi:10.1016/j.cell.2016.11.018
   PubMed Web of Science ®Google Scholar
• Allanore Y, Simms R, Distler O, et al. Systemic sclerosis. Nat Rev Dis Prim. 2015;1(1):1–21.
   Google Scholar
• Zhong L, Pope M, Shen Y, Hernandez JJ, Wu L. Prevalence and incidence of systemic sclerosis: a systematic review and meta-analysis. Int J Rheum Dis. 2019;22(12):2096–2107. doi:10.1111/1756-185X.13716
   Web of Science ®Google Scholar
• Gyger G, Baron M. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep. 2012;14(1):22–29. doi:10.1007/s11926-011-0217-3
   PubMed Web of Science ®Google Scholar
• McMahan ZH, Domsic RT, Zhu L, Medsger TA, Casciola‐Rosen L, Shah AA. Anti–RNPC‐3 (U11/U12) antibodies in systemic sclerosis in patients with moderate‐to‐severe gastrointestinal dysmotility. Arthritis Care Res. 2019;71(9):1164–1170. doi:10.1002/acr.23763
   Web of Science ®Google Scholar
• Suliman Y, Kafaja S, Oh SJ, et al. Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts. Clin Rheumatol. 2020;1–8.
   Web of Science ®Google Scholar
• Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009;94(6):1853–1878. doi:10.1210/jc.2008-2291
   PubMed Web of Science ®Google Scholar
• Ciobanu L, Dumitrascu DL. Gastrointestinal motility disorders in endocrine diseases. Pol Arch Med Wewn. 2011;121(4):129–136.
   Web of Science ®Google Scholar
• Abboud B, Daher R, Boujaoude J. Digestive manifestations of parathyroid disorders. World J Gastroenterol. 2011;17(36):4063. doi:10.3748/wjg.v17.i36.4063
   Web of Science ®Google Scholar
• Lenz HJ, Burlage M, Raedler A, Greten H. Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat. Gastroenterology. 1988;94(3):598–602. doi:10.1016/0016-5085(88)90229-6
   Web of Science ®Google Scholar
• Binder HJ. Effect of dexamethasone on electrolyte transport in the large intestine of the rat. Gastroenterology. 1978;75(2):212–217. doi:10.1016/0016-5085(78)90404-3
   Web of Science ®Google Scholar
• Tai Y-H, Decker RA, Marnane WG, Charney AN, Donowitz M. Effects of methylprednisolone on electrolyte transport by in vitro rat ileum. Am J Physiol Liver Physiol. 1981;240(5):G365–G370.
   Google Scholar
• Videlock EJ, Adeyemo M, Licudine A, et al. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology. 2009;137(6):1954–1962. doi:10.1053/j.gastro.2009.08.058
   PubMed Web of Science ®Google Scholar
• Kennedy PJ, Cryan JF, Quigley EMM, Dinan TG, Clarke G. A sustained hypothalamic-pituitary-adrenal axis response to acute psychosocial stress in irritable bowel syndrome. Psychol Med. 2014;44(14):3123–3134. doi:10.1017/S003329171400052X
   PubMed Web of Science ®Google Scholar
• Ng QX, Soh AYS, Loke W, Venkatanarayanan N, Lim DY, Yeo W-S. Systematic review with meta-analysis: the association between post-traumatic stress disorder and irritable bowel syndrome. J Gastroenterol Hepatol. 2019;34(1):68–73. doi:10.1111/jgh.14446
   Web of Science ®Google Scholar
• Barczyński M, Thor P. Reversible autonomic dysfunction in hyperthyroid patients affects gastric myoelectrical activity and emptying. Clin Auton Res. 2001;11(4):243–249. doi:10.1007/BF02298956
   Web of Science ®Google Scholar
• Ebert EC. The parathyroids and the gut. J Clin Gastroenterol. 2010;44(7):479–482. doi:10.1097/MCG.0b013e3181cd9d4c
   Web of Science ®Google Scholar
• Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Ther Adv Drug Saf. 2020;11:2042098620933741. doi:10.1177/2042098620933741
   Web of Science ®Google Scholar
• Carroll C, Hassanin A. Polypharmacy in the elderly-when good drugs lead to bad outcomes: a teachable moment. JAMA Intern Med. 2017;177(6):871. doi:10.1001/jamainternmed.2017.0911
   PubMed Web of Science ®Google Scholar
• Hajjar ER, Hanlon JT, Sloane RJ, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc. 2005;53(9):1518–1523. doi:10.1111/j.1532-5415.2005.53523.x
   PubMed Web of Science ®Google Scholar
• Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging. 2010;27(12):1019–1028. doi:10.2165/11584990-000000000-00000
   PubMed Web of Science ®Google Scholar
• Gu Q, Dillon CF, Burt VL. Prescription drug use continues to increase: U.S. prescription drug data for 2007–2008. NCHS Data Brief. 2010;42:1–8.
   PubMedGoogle Scholar
• Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473–482. doi:10.1001/jamainternmed.2015.8581
   PubMed Web of Science ®Google Scholar
• Poulsen JL, Nilsson M, Brock C, Sandberg TH, Krogh K, Drewes AM. The impact of opioid treatment on regional gastrointestinal transit. J Neurogastroenterol Motil. 2016;22(2):282–291. doi:10.5056/jnm15175
   PubMed Web of Science ®Google Scholar
• Chris-Olaiya A, Palmer W, Stancampiano F, et al. Medication use and polypharmacy in patients referred to a tertiary gastroenterology practice. Rom J Intern Med. 2020;58(4):228–232. doi:10.2478/rjim-2020-0016
   Web of Science ®Google Scholar
• Bytzer P. Dyspepsia as an adverse effect of drugs. Best Pract Res Clin Gastroenterol. 2010;24(2):109–120. doi:10.1016/j.bpg.2009.11.006
   Web of Science ®Google Scholar
• Barbara G, Grover M, Bercik P, et al. Rome foundation working team report on post-infection irritable bowel syndrome. Gastroenterology. 2019;156(1):46–58.e7. doi:10.1053/j.gastro.2018.07.011
   PubMed Web of Science ®Google Scholar
• Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis--clinical characteristics and long-term outcomes. Am J Gastroenterol. 2020;58(4):1501–1504.
   Google Scholar
• Gurusamy SR, Shah A, Talley NJ, et al. Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis. Am J Gastroenterol. 2021;116(5):935–942. doi:10.14309/ajg.0000000000001197
   PubMed Web of Science ®Google Scholar
• Shah A, Talley NJ, Jones M, et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. Am J Gastroenterol. 2020;115(2):190–201. doi:10.14309/ajg.0000000000000504
   PubMed Web of Science ®Google Scholar
• Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 2017;152(5):1042–1054.e1. doi:10.1053/j.gastro.2016.12.039
   PubMed Web of Science ®Google Scholar
• Pimentel M, Morales W, Pokkunuri V, et al. Autoimmunity links vinculin to the pathophysiology of chronic functional bowel changes following campylobacter jejuni infection in a rat model. Dig Dis Sci. 2015;60(5):1195–1205. doi:10.1007/s10620-014-3435-5
   PubMed Web of Science ®Google Scholar
• Smalley W, Falck-Ytter C, Carrasco-Labra A, Wani S, Lytvyn L, Falck-Ytter Y. AGA clinical practice guidelines on the laboratory evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBS-D). Gastroenterology. 2019;157(3):851–854. doi:10.1053/j.gastro.2019.07.004
   PubMed Web of Science ®Google Scholar
• Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006;131(2):445–450;quiz 660. doi:10.1053/j.gastro.2006.05.053
   Web of Science ®Google Scholar
• Camilleri M, Chedid V, Ford AC, et al. Gastroparesis. Nat Rev Dis Prim. 2018;4(1):1–19.
   Google Scholar
• Naftali T, Yishai R, Zangen T, Levine A. Post-infectious gastroparesis: clinical and electerogastrographic aspects. J Gastroenterol Hepatol. 2007;22(9):1423–1428. doi:10.1111/j.1440-1746.2006.04738.x
   Web of Science ®Google Scholar
• Oh JJ, Kim CH. Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history. Mayo Clin Proc. 1990;65(5):636–642. doi:10.1016/s0025-6196(12)65125-8
   Web of Science ®Google Scholar
• Brun P, Qesari M, Marconi PC, et al. Herpes simplex virus type 1 infects enteric neurons and triggers gut dysfunction via macrophage recruitment. Front Cell Infect Microbiol. 2018;8:74. doi:10.3389/fcimb.2018.00074
   Web of Science ®Google Scholar
• Grover M, Bernard CE, Pasricha PJ, et al. Diabetic and idiopathic gastroparesis is associated with loss of CD 206‐positive macrophages in the gastric antrum. Neurogastroenterol Motil. 2017;29(6):e13018. doi:10.1111/nmo.13018
   Web of Science ®Google Scholar